These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 27878737)
1. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency. Frampton JE Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676 [TBL] [Abstract][Full Text] [Related]
3. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639 [TBL] [Abstract][Full Text] [Related]
4. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030 [TBL] [Abstract][Full Text] [Related]
5. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251 [TBL] [Abstract][Full Text] [Related]
15. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency. Ezgü F Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536 [TBL] [Abstract][Full Text] [Related]
17. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa. Santos Silva E; Klaudel-Dreszler M; Bakuła A; Oliva T; Sousa T; Fernandes PC; Tylki-Szymańska A; Kamenets E; Martins E; Socha P Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):e77-e82. PubMed ID: 29705274 [TBL] [Abstract][Full Text] [Related]
18. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. Burton BK; Balwani M; Feillet F; Barić I; Burrow TA; Camarena Grande C; Coker M; Consuelo-Sánchez A; Deegan P; Di Rocco M; Enns GM; Erbe R; Ezgu F; Ficicioglu C; Furuya KN; Kane J; Laukaitis C; Mengel E; Neilan EG; Nightingale S; Peters H; Scarpa M; Schwab KO; Smolka V; Valayannopoulos V; Wood M; Goodman Z; Yang Y; Eckert S; Rojas-Caro S; Quinn AG N Engl J Med; 2015 Sep; 373(11):1010-20. PubMed ID: 26352813 [TBL] [Abstract][Full Text] [Related]
19. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy. Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531 [TBL] [Abstract][Full Text] [Related]
20. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Su K; Donaldson E; Sharma R Appl Clin Genet; 2016; 9():157-167. PubMed ID: 27799810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]